Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies
Authors
Keywords
Donor lymphocyte infusion, Stem cell transplantation, Peripheral blood, Graft-versus-host disease, Relapse
Journal
ANNALS OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-25
DOI
10.1007/s00277-018-3482-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma
- (2018) Yoshitaka Inoue et al. BONE MARROW TRANSPLANTATION
- TP53mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation
- (2016) Jan M. Middeke et al. BRITISH JOURNAL OF HAEMATOLOGY
- Similar incidence of severe acute GVHD and less severe chronic GVHD in PBSCT from unmanipulated, haploidentical donors compared with that from matched sibling donors for patients with haematological malignancies
- (2016) Hong-Hua Li et al. BRITISH JOURNAL OF HAEMATOLOGY
- Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukaemia undergoing allogeneic stem cell transplantation
- (2016) Philipp G. Hemmati et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
- (2015) Madan H. Jagasia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype
- (2015) J.-S. Ahn et al. HAEMATOLOGICA
- Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype
- (2015) J.-S. Ahn et al. HAEMATOLOGICA
- A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes
- (2013) F Locke et al. BONE MARROW TRANSPLANTATION
- High Alloreactivity of Low-Dose Prophylactic Donor Lymphocyte Infusion in Patients with Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation with an Alemtuzumab-Containing Conditioning Regimen
- (2012) Maria Liga et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation
- (2012) C.-H. Yan et al. BLOOD
- Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors
- (2012) Chen-Hua Yan et al. CLINICAL TRANSPLANTATION
- Induction of graft versus malignancy effect after unrelated allogeneic PBSCT using donor lymphocyte infusions derived from frozen aliquots of the original graft
- (2011) J Hasskarl et al. BONE MARROW TRANSPLANTATION
- Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis
- (2011) Y Wang et al. BONE MARROW TRANSPLANTATION
- Regression modeling of competing risk using R: an in depth guide for clinicians
- (2010) L Scrucca et al. BONE MARROW TRANSPLANTATION
- Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
- (2010) Michel Duval et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A
- (2010) Richard F. Schlenk et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial
- (2010) Birte Friedrichs et al. LANCET ONCOLOGY
- Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery
- (2009) Anna Dodero et al. BLOOD
- Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation
- (2009) Luca Vago et al. NEW ENGLAND JOURNAL OF MEDICINE
- Successful cell-mediated cytokine-activated immunotherapy for relapsed acute myeloid leukemia after hematopoietic stem cell transplantation
- (2008) Benjamin Gesundheit et al. AMERICAN JOURNAL OF HEMATOLOGY
- Modified Donor Lymphocyte Infusion after HLA-Mismatched/Haploidentical T Cell-replete Hematopoietic Stem Cell Transplantation for Prophylaxis of Relapse of Leukemia in Patients with Advanced Leukemia
- (2008) Xiao-Jun Huang et al. JOURNAL OF CLINICAL IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started